Janiczek Wealth Management, LLC Bio Techne Corp Transaction History

Janiczek Wealth Management, LLC

$475 Million
Q2 2024

A detailed history of Janiczek Wealth Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 107 shares of TECH stock, worth $7,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107

Previous 107 -0.0%

Holding current value

$7,353

Previous $7,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$52.83 - $78.22 $1,849 - $2,737	35 Added 48.61%	107 $8,000
Q2 2023 Jul 11, 2023	SELL	$73.76 - $85.98 $1,991 - $2,321	-27 Reduced 27.27%	72 $5,000
Q1 2023 Apr 21, 2023	SELL	$71.62 - $86.62 $11,315 - $13,685	-158 Reduced 61.48%	99 $7,000
Q4 2022 Jan 20, 2023	BUY	$80.67 - $352.29 $13,310 - $58,127	165 Added 179.35%	257 $0
Q3 2022 Oct 17, 2022	SELL	$282.54 - $391.85 $24,580 - $34,090	-87 Reduced 48.6%	92 $26,000
Q2 2022 Aug 03, 2022	SELL	$322.67 - $449.65 $1,613 - $2,248	-5 Reduced 2.72%	179 $69,000
Q1 2022 May 05, 2022	BUY	$353.85 - $487.79 $1,415 - $1,951	4 Added 2.22%	184 $80,000
Q4 2021 Feb 02, 2022	SELL	$456.15 - $525.06 $456 - $525	-1 Reduced 0.55%	180 $93,000
Q3 2021 Oct 19, 2021	BUY	$444.87 - $538.88 $6,673 - $8,083	15 Added 9.04%	181 $88,000
Q2 2021 Jul 28, 2021	BUY	$387.35 - $450.26 $3,098 - $3,602	8 Added 5.06%	166 $75,000
Q1 2021 Apr 28, 2021	BUY	$314.62 - $411.0 $6,607 - $8,631	21 Added 15.33%	158 $60,000
Q4 2020 Jan 26, 2021	BUY	$246.9 - $321.87 $31,109 - $40,555	126 Added 1145.45%	137 $44,000
Q3 2020 Oct 19, 2020	BUY	$232.22 - $282.96 $1,161 - $1,414	5 Added 83.33%	11 $3,000
Q2 2020 Jul 17, 2020	BUY	$185.43 - $279.56 $1,112 - $1,677	6 New	6 $2,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.

Account

Janiczek Wealth Management, LLC Bio Techne Corp Transaction History